ACCREDITATION STATEMENT
The American Association for Cancer Research (AACR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
CREDIT DESIGNATION STATEMENT
The AACR has designated this live activity for a maximum of 27.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CLAIMING (CME) CREDIT
Physicians and other health care professionals seeking AMA PRA Category 1 Credit(s)TM for this continuing medical education activity must complete the CME Request for Credit Survey below. Certificates will only be issued to those who complete the survey. CME certificates will be sent by email after the completion of the activity.
STATEMENT OF EDUCATIONAL NEED, TARGET AUDIENCE AND LEARNING OBJECTIVES
Advances in technology have led to exponential improvement in our understanding of tumor biology, cancer genetics and tumorigenesis. These advances have set the stage for collaborations between basic researchers, physicians, clinician-scientists and population scientists, to test novel risk assessment models, cancer screening techniques and cancer preventive interventions. These new prevention strategies have the potential to have a major impact on cancer incidence throughout the world. There is an urgent need to educate physicians and health practitioners to improve preventive care to individuals at risk of cancer. This meeting will bring together cancer prevention researchers from these various disciplines and will stimulate cross-disciplinary collaboration and adoption of new technology to identify, develop and test novel strategies to prevent cancer.
After participating in this CME activity, physicians should be able to:
- Recognize technological advances that will accelerate progress in cancer research to improve cancer risk assessment, early detection and early intervention in individuals at risk of cancer, with the ultimate goal of reducing cancer incidence in the US and the world;
- Integrate molecular assays and new screening techniques with classic risk factors (such as family history, behaviors such as tobacco use, environmental exposures and nutrition) to determine cancer susceptibility and predict lifetime risk;
- Assess and implement the results of new cancer screening clinical trials to provide state-of-the-art cancer screening procedures to at-risk individuals;
- Interpret scientific advances in the area of tobacco cessation and control to improve the medical care of current and past users of tobacco products;
- Critically assess the results of clinical trials of preventive strategies to better assess and explain the risks and benefits of cancer preventive interventions to individuals at risk of cancer; and
- Articulate the unique challenges to achieving global cancer prevention.
DISCLOSURE STATEMENT
It is the policy of the AACR that the information presented at AACR CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, the AACR will provide information that Scientific Program Committee members and speakers have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity. This disclosure information will be made available in the Program/Proceedings of this conference.
ACKNOWLEDGMENT OF FINANCIAL OR OTHER SUPPORT
This activity is supported by grants and will be disclosed at the activity.
QUESTIONS ABOUT CME?
Please contact the Office of CME at (215) 440-9300 or cme@aacr.org.